Likewise, our transcriptomics analysis revealed an important role for NLRX1 in pancreatic cancer cells through NF-κB, AKT, MAPK, and IL-6 signaling and highlights these pathways as likely mechanisms by which NLRX1 asserts its protective qualities in Pan02 cells. Here, AKT1 is linked to familial pancreatic carcinoma.